Fig. 4From: Efficacy of cardiometabolic drugs in reduction of epicardial adipose tissue: a systematic review and meta-analysisForest plots the effect of cardiometabolic drug on the epicardial adipose tissue thickening at 3- and 6-months follow-up. EAT thickness reduction was evaluated with the standardized difference in means (SMD) between 3 and 6Â months of follow-up. The diamond represents the estimated overall effect, while the squares represent each study with 95% CIBack to article page